Oromandibular dystonia associated with fluoxetine

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are commonly prescribed for major depression.
• Extrapyramidal symptoms (EPS) are known potential side effects of certain psychotropic medications.
• Tardive dystonia is a rare, persistent movement disorder.

Purpose of the Study:

• To report a rare case of persistent oromandibular dystonia and akathisia potentially induced by fluoxetine.
• To explore the possible neurobiological mechanisms underlying fluoxetine-induced movement disorders.

Main Methods:

• Case report of a 66-year-old female patient with major depression.
• Clinical observation of symptoms before, during, and after fluoxetine treatment.
• Assessment of treatment response to drug discontinuation and biperiden administration.

Main Results:

• The patient developed persistent oromandibular dystonia and mild akathisia during fluoxetine treatment.
• Symptoms significantly improved after discontinuing fluoxetine and initiating biperiden therapy.
• This suggests a potential causal link between fluoxetine and the observed movement disorder.

Conclusions:

• Fluoxetine may induce tardive dystonia and akathisia, possibly through serotonergic inhibition of dopaminergic pathways.
• This is the first reported case of persistent dystonia associated with fluoxetine.
• Further research is warranted to understand the neurochemical basis of SSRI-induced movement disorders.